Second CyberKnife Arrives at Georgetown University Hospital SUNNYVALE, Calif., June 6 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Georgetown University Hospital's second CyberKnife(R) Robotic Radiosurgery System
SUNNYVALE, Calif. , Sept. 23, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Nagoya City University Hospital in Aichi has treated the first cancer patient in Japan using the Radixact ® System with ClearRT ™ helical fan-beam kVCT imaging.
Leading Hospital will be the First in the Middle East to Offer Patients Precise Treatments with the Latest Generations of Both Systems SUNNYVALE, Calif. , July 11, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company is expanding access to its products in the Middle
Supplement Features 15 Peer Reviewed Papers Describing CyberKnife Radiosurgery for Brain and Spine Applications SUNNYVALE, Calif ., Jan. 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Neurosurgery, the official
First Patients Treated Using Next Generation CyberKnife System at Oklahoma CyberKnife Center SUNNYVALE, Calif., Aug. 5 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the first patients were treated using the next
Excellent Treatment Outcomes for a Wide Range of Tumor Types Demonstrated by Accuray CyberKnife and TomoTherapy Systems SUNNYVALE, Calif. , Nov. 2, 2015 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that studies on the clinical use of the leading-edge CyberKnife ® and
Studies of the InCise™ Multileaf Collimator (MLC) for the CyberKnife M6™ System Reinforce its Accuracy, Reliability and Precise Dose Delivery SUNNYVALE, Calif. , July 14, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that studies on the clinical use of the CyberKnife ®
SUNNYVALE, Calif. , July 24, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that studies validating the benefits of CyberKnife ® and Radixact ® System software innovations were shared by prominent physicists at the recent 61 st annual meeting of the American Association
Clinical Research Also Showcases Innovative Approaches to Expanding TomoTherapy Platform Functionality SUNNYVALE, Calif. , Aug. 4, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new studies demonstrating the TomoTherapy® System's leading-edge adaptive therapy
Data Also Underscores Potential Benefits of CyberKnife System Sub-millimeter Accuracy in Preserving Quality of Life after Treatment for Prostate Cancer MADISON, Wis. , March 26, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the 2024 Radiosurgery
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
